Pharmaceutical ResearchNews - Page 1

Could combining two drugs be better for treating prostate cancer?

A clinical trial discovered that combining testosterone-blocking drugs is better at treating prostate cancer than single drug treatment.

New synthetic antibiotic teixobactin shown to be effective against superbugs

Researchers have developed a new synthetic antibiotic, teixobactin, which is more effective than established drugs against superbugs.

Oral peptides: A new era in drug development

Newly-developed oral peptides will address a long-standing challenge in the pharmaceutical industry. Read more here.

Do opioid medicines truly relieve cancer pain?

Researchers examining data on opioid medicines have found gaps in evidence about their benefits for cancer pain. Read more here.

New discovery about chemotherapy drugs could have implications for medical research

A new study from the University of Wisconsin-Madison suggests that chemotherapy drugs may not reach their full potential. Read more here.

Researchers secure $1.2m grant in efforts to battle antibiotic resistance

Researchers are working to outrace two dangerous germs known for quickly developing antibiotic resistance. Read more here.

Evaluation of ANK-101 and KEYTRUDA® combination in patients with advanced solid tumours

Ankyra have announced a clinical trial to evaluate the combination of ANK-101 and KEYTRUDA® in patients with advanced solid tumours.

How can pharmacists improve access to HPV vaccines?

Learn more about a system developed by pharmacists that will makes access to HPV vaccines quicker and easier.

New antibiotics could pave the way for successful bacterial infection treatment

Learn how a group of drugs commonly used in cancer treatments could possibly be a successful bacterial infection treatment.

New drug delivery system could significantly improve cancer treatments

A new drug delivery system balances the acidic environment in a tumour and improves the fighting activity of cancer treatments.

Pfizer’s LITFULO approved for adolescents and adults with severe alopecia areata by European Commission

The EC has granted marketing authorisation for Pfizer’s LITFULO to treat adults and adolescents 12 years older with severe alopecia areata.

Addressing the key translational challenges of regenerative medicine

Sophie Mountcastle, Science Manager of the UK Regenerative Medicine Platform, describes the current regenerative medicine landscape in the UK.

Analysing the effects of long-period space flight on cardiac atrophy

Novel research conducted on mouse models may help to combat cardiac atrophy experienced by astronauts during long-period space flight.

Identifying natural product medications with machine learning algorithms

Machine learning algorithms will potentially advance the search for natural product drugs for cancers, viral infections, and other conditions.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd